New Issue of Science Signaling
Science Signaling's latest issue covers lncRNA therapies and AI in cancer neuroscience.
The issue highlights the potential of long non-coding RNAs (lncRNAs) as therapeutic targets, particularly in diseases where protein-coding genes are difficult to modulate. Artificial intelligence is increasingly being used to model and understand the complexities of cancer neuroscience, offering new avenues for treatment. Science Signaling is a journal from the American Association for the Advancement of Science (AAAS).
